Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide:: the structural basis of redox priming

被引:66
作者
Schmid, E
Hotz-Wagenblatt, A
Hack, V
Dröge, W
机构
[1] Deutsch Krebsforschungszentrum, Div Immunochem, D-69120 Heidelberg, Germany
[2] Deutsch Krebsforschungszentrum, Div Mol Biophys, D-69120 Heidelberg, Germany
关键词
insulin responsiveness; redox regulation; signal transduction; tyrosine kinase;
D O I
10.1096/fasebj.13.12.1491
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Signaling by insulin requires autophosphorylation of the insulin receptor kinase (IRK) at Tyr1158, Tyr1162, and Tyr1163, Earlier experiments with P-32-gamma-ATP indicated that the nonphosphorylated IRK (IRK-0P) is relatively inactive, and crystallogaphic data indicated that the ATP binding site of IRK-OP is blocked by its activation loop. We now show that phosphocreatine (PCr) in combination with hydrogen peroxide serves as an alternative phosphate donor and that ATP and PCr use distinct binding sites. Whereas phosphorylation of the Wt by ATP is inhibited by the nonhydrolyzable competitor adenylyl-imidodiphosphate, phosphorylation by PCr is enhanced, The IRK mutant Try1158Phe showed no phosphorylation with PCr but almost normal phosphorylation with ATP, whereas: Tyr1162Phe was phosphorylated well with PCr but less then normal with ATP, 3-Dimensional models of IRK-OP revealed that the conversion of any of the four cysteine residues 1056, 1138, 1234, and 1245 into sulfenic acid produces structural changes that bring Tyr1158 into close contact with Asp1083 and render the well-known catalytic site at Asp1132 and Tyr1162 accessible from a direction that differs from the known ATP binding site. The mutant Cys1158Ala, in contrast, showed relatively inaccessible catalytic sites and weak catalytic activity in functional experiments, Taken together, these findings indicate that 'redox priming' of the IRK facilitates its autophosphorylation by PCr in the activation loop.
引用
收藏
页码:1491 / 1500
页数:10
相关论文
共 62 条
  • [1] THIOL-SPECIFIC BIOTINYLATION OF THE INSULIN-RECEPTOR IN PERMEABILIZED CELLS ENHANCES RECEPTOR FUNCTION
    BERNIER, M
    NADIV, O
    KOLE, HK
    [J]. BIOCHEMISTRY, 1995, 34 (26) : 8357 - 8364
  • [2] A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance
    Bruning, JC
    Michael, MD
    Winnay, JN
    Hayashi, T
    Horsch, D
    Accili, D
    Goodyear, LJ
    Kahn, CR
    [J]. MOLECULAR CELL, 1998, 2 (05) : 559 - 569
  • [3] PHYSIOLOGY IN INSULIN IN MAN
    CAHILL, GF
    [J]. DIABETES, 1971, 20 (12) : 785 - &
  • [4] Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats
    Carvalho, CRO
    Brenelli, SL
    Silva, AC
    Nunes, ALB
    Velloso, LA
    Saad, MJA
    [J]. ENDOCRINOLOGY, 1996, 137 (01) : 151 - 159
  • [5] Crystal structure of a novel human peroxidase enzyme at 2.0 Å resolution
    Choi, HJ
    Kang, SW
    Yang, CH
    Rhee, SG
    Ryu, SE
    [J]. NATURE STRUCTURAL BIOLOGY, 1998, 5 (05) : 400 - 406
  • [6] SULFHYDRYL AGENTS MODULATE INSULIN-RECEPTOR AND EPIDERMAL GROWTH-FACTOR (EGF)-RECEPTOR KINASE VIA REACTION WITH INTRACELLULAR RECEPTOR DOMAINS - DIFFERENTIAL-EFFECTS ON BASAL VERSUS ACTIVATED RECEPTORS
    CLARK, S
    KONSTANTOPOULOS, N
    [J]. BIOCHEMICAL JOURNAL, 1993, 292 : 217 - 223
  • [7] A function-structure model for NGF-activated TRK
    Cunningham, ME
    Greene, LA
    [J]. EMBO JOURNAL, 1998, 17 (24) : 7282 - 7293
  • [8] REDUCED GLYCOGEN-SYNTHASE ACTIVITY IN SKELETAL-MUSCLE FROM OBESE PATIENTS WITH AND WITHOUT TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS
    DAMSBO, P
    VAAG, A
    HOTHERNIELSEN, O
    BECKNIELSEN, H
    [J]. DIABETOLOGIA, 1991, 34 (04) : 239 - 245
  • [9] FREE-RADICALS AND TISSUE-DAMAGE PRODUCED BY EXERCISE
    DAVIES, KJA
    QUINTANILHA, AT
    BROOKS, GA
    PACKER, L
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 107 (04) : 1198 - 1205
  • [10] DeFronzo RA, 1997, DIABETES REV, V5, P177